These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 21132767)

  • 21. Tests on trial. Jobs and reputation ride on unproven drug screens.
    Hawkins D
    US News World Rep; 2002 Aug; 133(6):46-8. PubMed ID: 12195773
    [No Abstract]   [Full Text] [Related]  

  • 22. New biorepository guidelines raise concerns.
    Hede K
    J Natl Cancer Inst; 2006 Jul; 98(14):952-4. PubMed ID: 16849672
    [No Abstract]   [Full Text] [Related]  

  • 23. [Adulteration of urine drug testing--an exaggerated cause of concern].
    Beck O; Bohlin M; Bragd F; Bragd J; Greitz O
    Lakartidningen; 2000 Feb; 97(7):703-6. PubMed ID: 10740378
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adulterants and drugs-of- abuse testing: an update.
    Dasgupta A
    MLO Med Lab Obs; 2008 Feb; 40(2):24-5. PubMed ID: 18405221
    [No Abstract]   [Full Text] [Related]  

  • 25. A delicate balance protects everyone's rights.
    Overman S
    HRMAGAZINE; 1990 Nov; 35(11):36-9. PubMed ID: 10108943
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cut-off and toxicity levels for drugs-of-abuse testing.
    MLO Med Lab Obs; 2003 Aug; 35(8 Suppl):8-9. PubMed ID: 12964303
    [No Abstract]   [Full Text] [Related]  

  • 27. Legal issues in oral fluid testing.
    Kadehjian L
    Forensic Sci Int; 2005 Jun; 150(2-3):151-60. PubMed ID: 15944055
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preanalytic aspects in postmortem toxicology.
    Skopp G
    Forensic Sci Int; 2004 Jun; 142(2-3):75-100. PubMed ID: 15172073
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Meeting JCAHO's new tissue standards.
    Sawchuk M
    OR Manager; 2005 Jun; 21(6):19-20. PubMed ID: 16022239
    [No Abstract]   [Full Text] [Related]  

  • 30. Progress reported in hospital employee drug testing programs.
    Hosp Secur Saf Manage; 1991 Feb; 11(10):1-4. PubMed ID: 10111195
    [No Abstract]   [Full Text] [Related]  

  • 31. Sample preparation for drugs-of-abuse analysis: a new perspective.
    Rummel M
    MLO Med Lab Obs; 2012 Mar; 44(3):12. PubMed ID: 22514944
    [No Abstract]   [Full Text] [Related]  

  • 32. The medical review officer and workplace drug testing.
    Clark HW
    J Psychoactive Drugs; 1990; 22(4):435-45. PubMed ID: 2096188
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preanalytical mixing of whole-blood specimens in the context of the Athlete Passport.
    Ashenden M; Clarke A; Sharpe K; d'Onofrio G; Allbon G; Gore CJ
    J Clin Pathol; 2012 Jan; 65(1):8-13. PubMed ID: 22049219
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protecting medical laboratories from tort liability for drug testing. The amorphous concept of duty.
    Lockard DW
    J Leg Med; 1996 Sep; 17(3):427-55. PubMed ID: 9111772
    [No Abstract]   [Full Text] [Related]  

  • 35. Pitfalls in industrial drug screening.
    Adams J
    J Miss State Med Assoc; 1998 Jun; 39(6):214-7. PubMed ID: 9635387
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The U.S. Mandatory Guidelines for Federal Workplace Drug Testing Programs: current status and future considerations.
    Bush DM
    Forensic Sci Int; 2008 Jan; 174(2-3):111-9. PubMed ID: 17434274
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drug and alcohol testing. DOT's, Part 40: Implications for employers.
    Eden T
    Occup Health Saf; 2000 Jul; 69(7):84-6, 88. PubMed ID: 10902123
    [No Abstract]   [Full Text] [Related]  

  • 38. All-applicant drug testing in hospitals: overcoming physician protests.
    Hosp Secur Saf Manage; 1993 Feb; 13(10):1-3. PubMed ID: 10126158
    [No Abstract]   [Full Text] [Related]  

  • 39. Hospitals begin to implement worker drug-testing programs.
    Eubanks P
    Hospitals; 1992 Oct; 66(20):38, 40, 42. PubMed ID: 1398602
    [No Abstract]   [Full Text] [Related]  

  • 40. Drug-testing methods and clinical interpretations of test results.
    Kapur BM
    Bull Narc; 1993; 45(2):115-54. PubMed ID: 7920539
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.